Ella Instrument- Automated Immunoassay Machine acquisition

The National Institutes of Health, specifically the National Institute of Neurological Disorders and Stroke (NINDS) Translational Neuroradiology Section (TNS), requires the acquisition of an Ella Automated Immunoassay Machine. This high-throughput system from Bio-Techne is utilized for multiplexed, protein-based analysis of serum and plasma samples to support research into multiple sclerosis and neuroinflammatory pathologies. The equipment enables the reproducible quantification of critical biomarkers, including neurofilament light chain and glial fibrillary acidic protein, which serve as indicators for axonal damage and astrocyte activation in the central nervous system.

This pre-solicitation, identified by solicitation number 75N98026Q00510, is classified under NAICS 334516 for Analytical Laboratory Instrument Manufacturing and PSC 6640 for Laboratory Equipment and Supplies. There is no set-aside designated for this requirement. The primary place of performance is Bethesda, MD, and the agency has established a response deadline of June 8, 2026.

Administrative oversight for this procurement is provided by the National Institutes of Health OLAO. The notice was published on June 3, 2026, and includes one attachment titled index.pdf. Vishnuvajjala Hanumanth Rao serves as the point of contact for this acquisition, which is intended to maintain the rigor and reproducibility necessary for ongoing translational neuroimmunology investigations.